Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
57:46
October 14, 2025 - PBS News Hour full episode
57:46
October 13, 2025 - PBS News Hour full episode
26:45
October 12, 2025 - PBS News Weekend full episode
26:45
October 11, 2025 - PBS News Weekend full episode
57:46
October 10, 2025 - PBS News Hour full episode
57:46
October 9, 2025 - PBS News Hour full episode
57:46
October 8, 2025 - PBS News Hour full episode
57:46
October 7, 2025 - PBS News Hour full episode
56:45
October 6, 2025 - PBS News Hour full episode
26:45
October 5, 2025 - PBS News Weekend full episode
26:45
October 4, 2025 - PBS News Weekend full episode
57:46
October 3, 2025 - PBS News Hour full episode